Market share of Yiling Pharmaceutical's drugs in China 2017-2022
In 2022, Yiling Pharmaceutical's cardiovascular internal drugs had a market share of approximately 6.4 percent in the retail market in China. In general, the market shares showed constant and slight fluctuations.